Fundraising Fox

TreeFrog Therapeutics

Bordeaux, FR · Founded 2018 · 158 employees on LinkedIn · 1 known investors

TreeFrog develops C-Stem, a GMP-compliant technology platform for scalable production of cell therapies that optimizes yield and quality while minimizing cell damage. The platform serves biotech and cell therapy companies from early-stage research through commercial manufacturing.

Investors · 1

Funding

SEC filings, press & company announcements

$75M disclosed across 1 round · 2021

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does TreeFrog Therapeutics do?
TreeFrog develops C-Stem, a GMP-compliant technology platform for scalable production of cell therapies that optimizes yield and quality while minimizing cell damage. The platform serves biotech and cell therapy companies from early-stage research through commercial manufacturing.
Who are TreeFrog Therapeutics's investors?
TreeFrog Therapeutics's investors include AQUITI Gestion.
How much funding has TreeFrog Therapeutics raised?
TreeFrog Therapeutics has disclosed $75M raised across 1 round.
Where is TreeFrog Therapeutics headquartered?
TreeFrog Therapeutics is headquartered in Bordeaux, FR.